Medicare Enrolled
Dr. Waina Cheng, MD
Medical Oncology · Pompton Plains, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cheng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheng?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cheng
Dr. Waina Cheng is a medical oncology specialist in Pompton Plains, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Cheng performed 3,347 Medicare services across 1,385 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cheng received a total of $6,493 from 56 pharmaceutical and/or device companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cheng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 39% volume in NJ
$6,493 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,347
Medicare services
Top 39% in NJ for medical oncology
1,385
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~186 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
814 | $100 | $343 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
556 | $102 | $363 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
256 | $70 | $247 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
217 | $148 | $733 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
185 | $8 | $20 |
| Amylase enzyme level test A blood test that measures the amount of amylase, an enzyme produced by the pancreas and salivary glands, to help evaluate pancreatic health. |
133 | $6 | $10 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
132 | $4 | $7 |
| Total protein level test, body fluid A laboratory test that measures the total amount of protein in a sample of body fluid. This helps evaluate the composition of fluids such as cerebrospinal fluid, pleural fluid, or ascites. |
126 | $4 | $6 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
110 | $7 | $12 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
104 | $6 | $10 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
103 | $7 | $11 |
| Albumin level test A blood test that measures the amount of albumin, a protein made by the liver, in your body. |
73 | $5 | $8 |
| Total bilirubin level test A blood test that measures the total amount of bilirubin, a waste product from the breakdown of red blood cells, in your body. |
73 | $5 | $8 |
| Alkaline phosphatase level test A blood test that measures the level of alkaline phosphatase, an enzyme found in the liver and bones. |
73 | $5 | $8 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
73 | $5 | $8 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
73 | $5 | $9 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
67 | $8 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
63 | $10 | $17 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $138 | $551 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $99 | $364 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $142 | $487 |
| New patient office visit, complex (60-74 min) | 18 | $192 | $691 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
14 | $8 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,493
Total received (2018-2024)
Avg $928/year across 7 years
Top 17% in NJ for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
400
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,493 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$973
2023
$971
2022
$1,196
2021
$895
2020
$790
2019
$988
2018
$680
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$165
Merck Sharp & Dohme LLC
$164
Janssen Biotech, Inc.
$145
E.R. Squibb & Sons, L.L.C.
$94
AstraZeneca Pharmaceuticals LP
$82
Bayer Healthcare Pharmaceuticals Inc.
$43
GlaxoSmithKline, LLC.
$41
Celgene Corporation
$38
Genentech USA, Inc.
$32
PharmaEssentia USA Corporation
$29
TAIHO ONCOLOGY, INC.
$23
SOBI, INC
$19
Incyte Corporation
$18
Mirati Therapeutics, Inc.
$18
EMD Serono, Inc.
$17
Rigel Pharmaceuticals, Inc.
$16
PFIZER INC.
$15
Exelixis Inc.
$14
Top 3 companies account for 48.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$798
Novartis Pharmaceuticals Corporation
$576
Janssen Biotech, Inc.
$457
E.R. Squibb & Sons, L.L.C.
$432
Merck Sharp & Dohme Corporation
$357
Amgen Inc.
$333
PFIZER INC.
$286
Genentech USA, Inc.
$250
Daiichi Sankyo Inc.
$246
GENZYME CORPORATION
$227
Merck Sharp & Dohme LLC
$221
Incyte Corporation
$194
Celgene Corporation
$156
Lilly USA, LLC
$150
Bayer HealthCare Pharmaceuticals Inc.
$144
Gilead Sciences, Inc.
$132
Ipsen Biopharmaceuticals, Inc
$127
GlaxoSmithKline, LLC.
$99
Regeneron Healthcare Solutions, Inc.
$80
Kite Pharma, Inc.
$74
Takeda Pharmaceuticals U.S.A., Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$70
Rigel Pharmaceuticals, Inc.
$61
Puma Biotechnology, Inc.
$58
ARRAY BIOPHARMA INC
$57
Astellas Pharma US Inc
$52
Mirati Therapeutics, Inc.
$48
Myriad Genetic Laboratories, Inc.
$47
PharmaEssentia USA Corporation
$44
Seattle Genetics, Inc.
$43
EMD Serono, Inc.
$42
Seagen Inc.
$41
Teva Pharmaceuticals USA, Inc.
$37
Adaptive Biotechnologies Corporation
$35
Karyopharm Therapeutics Inc.
$34
Sumitomo Pharma America, Inc.
$30
Eisai Inc.
$30
Myovant Sciences Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
CTI BioPharma Corp.
$29
Exelixis Inc.
$27
TAIHO ONCOLOGY, INC.
$23
JAZZ PHARMACEUTICALS INC.
$19
SOBI, INC
$19
Novo Nordisk Inc
$17
Stemline Therapeutics Inc.
$16
Jazz Pharmaceuticals Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
MorphoSys, US Inc.
$16
Foundation Medicine, Inc.
$15
ImmunoGen, Inc.
$15
Clovis Oncology, Inc.
$15
Pharmacyclics LLC, An AbbVie Company
$14
ABBVIE INC.
$14
Kyowa Kirin, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 28.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · ENTRESTO · ERLEADA · Elahere · Enhertu · Erleada · FARESTON · FASLODEX · FOUNDATIONONE · Fabhalta · GILOTRIF · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LEQVIO · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MYRISK · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · Perjeta · Pomalyst · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SCEMBLIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Trodelvy · Truxima · Ultomiris · VENCLEXTA · VERZENIO · Venclexta · Vonjo · Wegovy · XALKORI · XARELTO · XGEVA · XPOVIO · Xofigo · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
324
Per 100K population
63.5
County median income
$134,929
Nearest hospital
CHILTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cheng is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NJ peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cheng experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Cheng performed 814 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheng receive payments from pharmaceutical companies?
Yes. Dr. Cheng received a total of $6,493 from 56 companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheng's costs compare to other medical oncologists in Pompton Plains?
Dr. Cheng's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Pompton Plains
Browse medical oncologists in Pompton Plains ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NJ
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NJ
Which NJ medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology